These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26043170)

  • 21. Immunometabolism during Mycobacterium tuberculosis Infection.
    Howard NC; Khader SA
    Trends Microbiol; 2020 Oct; 28(10):832-850. PubMed ID: 32409147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
    Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
    BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The most frequent
    Togo ACG; Kodio O; Diarra B; Sanogo M; Coulibaly G; Bane S; Diallo F; Somboro AM; Cisse AB; Baya B; Goita D; Diabate S; Kone B; Sarro YDS; Maiga M; Toloba Y; Belson M; Orsega S; Dao S; Murphy RL; Siddiqui S; Doumbia S; Diallo S
    Int J Mycobacteriol; 2017; 6(4):379-386. PubMed ID: 29171452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection.
    Quan Y; Xiong L; Chen J; Zhang HY
    J Biomol Struct Dyn; 2017 Feb; 35(3):616-621. PubMed ID: 26900080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
    Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
    Front Immunol; 2020; 11():680. PubMed ID: 32411131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular strain typing of Mycobacterium tuberculosis complex in Bamako, Mali.
    Traore B; Diarra B; Dembele BP; Somboro AM; Hammond AS; Siddiqui S; Maiga M; Kone B; Sarro YS; Washington J; Parta M; Coulibaly N; M'baye O; Diallo S; Koita O; Tounkara A; Polis MA
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):911-6. PubMed ID: 22508197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time.
    Téllez-Navarrete NA; Ramon-Luing LA; Muñoz-Torrico M; Preciado-García M; Medina-Quero K; Hernandez-Pando R; Chavez-Galan L
    Mol Med; 2021 Jul; 27(1):76. PubMed ID: 34261449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.
    Manca C; Koo MS; Peixoto B; Fallows D; Kaplan G; Subbian S
    PLoS One; 2013; 8(8):e74082. PubMed ID: 24015316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.
    Resende Co T; Hirsch CS; Toossi Z; Dietze R; Ribeiro-Rodrigues R
    Clin Exp Immunol; 2007 Jan; 147(1):45-52. PubMed ID: 17177962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
    Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
    Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia.
    Mendy J; Togun T; Owolabi O; Donkor S; Ota MO; Sutherland JS
    BMC Infect Dis; 2016 Mar; 16():115. PubMed ID: 26951717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis-specific plasmablast levels are differentially modulated in tuberculosis infection and disease.
    Gindeh A; Owolabi O; Donkor S; Sutherland JS
    Tuberculosis (Edinb); 2020 Sep; 124():101978. PubMed ID: 32781412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages.
    Roy S; Schmeier S; Kaczkowski B; Arner E; Alam T; Ozturk M; Tamgue O; Parihar SP; Kawaji H; Itoh M; Lassmann T; Carninci P; Hayashizaki Y; Forrest ARR; Guler R; Bajic VB; Brombacher F; Suzuki H
    Sci Rep; 2018 Apr; 8(1):6758. PubMed ID: 29712924
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Shim D; Kim H; Shin SJ
    Front Immunol; 2020; 11():910. PubMed ID: 32477367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
    Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
    PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.
    Ekins S; Madrid PB; Sarker M; Li SG; Mittal N; Kumar P; Wang X; Stratton TP; Zimmerman M; Talcott C; Bourbon P; Travers M; Yadav M; Freundlich JS
    PLoS One; 2015; 10(10):e0141076. PubMed ID: 26517557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.